Joseph A. M. Truluck
2022
In 2022, Joseph A. M. Truluck earned a total compensation of $442.6K as Chief Financial Officer at ADIAL PHARMACEUTICALS, a 29% decrease compared to previous year.
Compensation breakdown
| Option Awards | $162,920 |
|---|---|
| Salary | $267,500 |
| Other | $12,200 |
| Total | $442,620 |
Truluck received $267.5K in salary, accounting for 60% of the total pay in 2022.
Truluck also received $162.9K in option awards and $12.2K in other compensation.
Rankings
In 2022, Joseph A. M. Truluck's compensation ranked 4,548th out of 5,760 executives tracked by ExecPay. In other words, Truluck earned more than 21.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,548 out of 5,760 | 21st |
Division Manufacturing | 2,549 out of 3,136 | 19th |
Major group Chemicals And Allied Products | 1,220 out of 1,422 | 14th |
Industry group Drugs | 1,146 out of 1,323 | 13th |
Industry Pharmaceutical Preparations | 836 out of 969 | 14th |
Source: SEC filing on September 29, 2023.
Truluck's colleagues
We found three more compensation records of executives who worked with Joseph A. M. Truluck at ADIAL PHARMACEUTICALS in 2022.
News
ADIAL PHARMACEUTICALS CEO Cary Claiborne's 2023 pay falls 21% to $802K
September 27, 2024
ADIAL PHARMACEUTICALS CEO Cary Claiborne's 2022 pay jumps 118% to $1M
September 29, 2023
ADIAL PHARMACEUTICALS CEO William Stilley's 2021 pay rises 8% to $1.2M
September 1, 2022
ADIAL PHARMACEUTICALS CEO William Stilley's 2019 pay jumps 95% to $2.4M
July 20, 2020
ADIAL PHARMACEUTICALS CEO William Stilley's 2018 pay jumps 232% to $1.2M
July 8, 2019